2021 American Society of Clinical Oncology Annual Meeting Coverage

Every June, the American Society of Clinical Oncology Annual Meeting brings together clinicians, researchers, and advocates to discuss the latest cancer study results. We’re proud to present our coverage below.

Chemotherapy for Breast Cancer Doesn’t Seem To Increase Risk of COVID-19 Infection or Death

More Abdominal Fat Linked to Worse Outcomes for Black Women Who Are Breast Cancer Survivors

Ultralow MammaPrint Score Means Excellent Breast Cancer Outcomes

Most Women With Metastatic Breast Cancer Have Troubling Treatment Side Effects, Willing To Discuss Dosing Options With Doctor

Adding Tukysa to Standard of Care Continues To Improve Survival in Advanced-Stage HER2-Positive Breast Cancer

Kisqali-Faslodex Combo Continues To Improve Overall Survival in Advanced-Stage, Hormone-Receptor-Positive Breast Cancer in Postmenopausal Women

Ibrance-Faslodex Combo Continues To Improve Overall Survival in Advanced-Stage, Hormone-Receptor-Positive Breast Cancer

Lynparza Offers Benefits for Early-Stage HER2-Negative Breast Cancer With BRCA1/2 Mutation

Breast Cancer Research at the 2021 ASCO Annual Meeting, with Jennifer Litton, MD